Resolvin D1 level during different trimesters of pregnancy for predicting the risk of fetal growth retardation in elderly pregnancy

References

• Correa-de-Araujo R, Yoon SSS. Clinical outcomes in high-risk pregnancies due to advanced maternal age. J Womens Health (Larchmt). 2021;30(2):160–167. doi:10.1089/jwh.2020.8860.
   PubMed Web of Science ®Google Scholar
• Lees CC, Romero R, Stampalija T, et al. Clinical opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach. Am J Obstet Gynecol. 2022;226(3):366–378. doi:10.1016/j.ajog.2021.11.1357.
   PubMed Web of Science ®Google Scholar
• Li, Hui, Fan, Cuifang, Mubarik, Sumaira, et al. The trend in delayed childbearing and its potential consequences on pregnancy outcomes: a single center 9-years retrospective cohort study in Hubei, China. BMC Pregnancy Childbirth, 2022;22:514. doi:10.1186/s12884-022-04807-8.
   PubMed Web of Science ®Google Scholar
• Guarga Montori M, Álvarez Martínez A, Luna Álvarez C, et al. Advanced maternal age and adverse pregnancy outcomes: a cohort study. Taiwan J Obstet Gynecol. 2021;60(1):119–124. doi:10.1016/j.tjog.2020.11.018.
   PubMed Web of Science ®Google Scholar
• Huang C, Jiang Q, Su W, et al. Age-specific effects on adverse pregnancy outcomes vary by maternal characteristics: a population-based retrospective study in xiamen, China. BMC Public Health. 2023;23(1):326. doi:10.1186/s12889-023-15235-4.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou J, Chen Y, et al. Pregnancy outcomes after frozen embryo transfer and fresh embryo transfer in women of advanced maternal age: single-Center experience. J Clin Med. 2022;11(21):6395. doi:10.3390/jcm11216395.
   Web of Science ®Google Scholar
• Pels A, Beune IM, van Wassenaer-Leemhuis AG, et al. Early-onset fetal growth restriction: a systematic review on mortality and morbidity. Acta Obstet Gynecol Scand. 2020;99(2):153–166. doi:10.1111/aogs.13702.
   PubMed Web of Science ®Google Scholar
• Lubrano C, Taricco E, Coco C, et al. Perinatal and neonatal outcomes in fetal growth restriction and small for gestational age. J Clin Med. 2022;11(10):2729. doi:10.3390/jcm11102729.
   PubMed Web of Science ®Google Scholar
• D’Agostin M, Di Sipio Morgia C, Vento G, et al. Long-term implications of fetal growth restriction. World J Clin Cases. 2023;11(13):2855–2863. doi:10.12998/wjcc.v11.i13.2855.
   PubMed Web of Science ®Google Scholar
• Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J Physiol. 2016;594(4):807–823. doi:10.1113/JP271402.
   PubMed Web of Science ®Google Scholar
• Martins JG, Biggio JR, Abuhamad A, Society for Maternal-Fetal Medicine. Electronic address pso., et al. Society for maternal-fetal medicine consult series #52: diagnosis and management of fetal growth restriction: (replaces clinical guideline number 3, april 2012). Am J Obstet Gynecol. 2020;223(4):B2–B17. doi:10.1016/j.ajog.2020.05.010.
   PubMed Web of Science ®Google Scholar
• Bettiol A, Avagliano L, Lombardi N, et al. Pharmacological interventions for the prevention of fetal growth restriction: a systematic review and network meta-analysis. Clin Pharmacol Ther. 2021;110(1):189–199. doi:10.1002/cpt.2164.
   PubMed Web of Science ®Google Scholar
• Roohbakhsh A, Etemad L, Karimi G. Resolvin D1: a key endogenous inhibitor of neuroinflammation. Biofactors. 2022;48(5):1005–1026. doi:10.1002/biof.1891.
   PubMed Web of Science ®Google Scholar
• Morita M, Wu S, Kobayashi Y. Stereocontrolled synthesis of resolvin D1. Org Biomol Chem. 2019;17(8):2212–2222. doi:10.1039/c8ob03128b.
   PubMed Web of Science ®Google Scholar
• Li A, Zhang L, Li J, et al. Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis. J Cell Mol Med. 2020;24(22):13397–13407. doi:10.1111/jcmm.15963.
   PubMed Web of Science ®Google Scholar
• Dmitrieva N, Suess G, Shirley R. Resolvins RvD1 and 17(R)-RvD1 alleviate signs of inflammation in a rat model of endometriosis. Fertil Steril. 2014;102(4):1191–1196. doi:10.1016/j.fertnstert.2014.06.046.
   PubMed Web of Science ®Google Scholar
• Brien ME, Boufaied I, Bernard N, et al. Specific inflammatory profile in each pregnancy complication: a comparative study. Am J Reprod Immunol. 2020;84:e13316.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S745–S761. doi:10.1016/j.ajog.2017.11.577.
   PubMedGoogle Scholar
• Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2022;226(2S):S988–S1005. doi:10.1016/j.ajog.2021.11.022.
   PubMedGoogle Scholar
• Fasoulakis Z, Koutras A, Antsaklis P, et al. Intrauterine growth restriction due to gestational diabetes: from pathophysiology to diagnosis and management. Medicina (Kaunas). 2023;59(6):59. doi:10.3390/medicina59061139.
   Web of Science ®Google Scholar
• Oliveira Perucci L, Pereira Santos TA, Campi Santos P, et al. Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma. Am J Reprod Immunol. 2020;83:e13206.
   PubMed Web of Science ®Google Scholar
• Perucci LO, de Castro Pinto KM, da Silva SPG, et al. Longitudinal assessment of leukotriene B4, lipoxin A4, and resolvin D1 plasma levels in pregnant women with risk factors for preeclampsia. Clin Biochem. 2021;98:24–28. doi:10.1016/j.clinbiochem.2021.09.002.
   PubMed Web of Science ®Google Scholar
• Maner-Smith KM, Ferranti E, Dunlop A, et al. African American women with cardiometabolic complications of pregnancy have decreased serum abundance of specialized Pro-Resolving lipid mediators and endocannabinoids. Nutrients. 2022;15(1):15. doi:10.3390/nu15010140.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu J. MicroRNA-206 predicts raised fetal growth retardation risk through the interaction with vascular endothelial growth factor in pregnancies. Medicine (Baltimore). 2020;99(7):e18897. doi:10.1097/MD.0000000000018897.
   PubMed Web of Science ®Google Scholar
• Fetal Growth Restriction. ACOG practice bulletin, number 227. Obstet Gynecol. 2021;137:e16–e28.
   PubMed Web of Science ®Google Scholar
• Miremerg H, Frig O, Rona S, et al. Is advanced maternal age associated with placental vascular malperfusion? A prospective study from a single tertiary center. Arch Gynecol Obstet. 2020;301(6):1441–1447. doi:10.1007/s00404-020-05562-x.
   PubMed Web of Science ®Google Scholar
• Aldahmash WM, Alwasel SH, Aljerian K. Gestational diabetes mellitus induces placental vasculopathies. Environ Sci Pollut Res Int. 2022;29(13):19860–19868. doi:10.1007/s11356-021-17267-y.
   PubMed Web of Science ®Google Scholar
• Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh). 1954;16(4):330–342. doi:10.1530/acta.0.0160330.
   PubMedGoogle Scholar
• Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66 Suppl 2(Suppl 2):14–20. doi:10.1159/000371628.
   PubMed Web of Science ®Google Scholar
• Laron Z. Insulin–a growth hormone. Arch Physiol Biochem. 2008;114(1):11–16. doi:10.1080/13813450801928356.
   PubMedGoogle Scholar
• Li M, Hinkle SN, Grantz KL, et al. Glycaemic status during pregnancy and longitudinal measures of fetal growth in a multi-racial US population: a prospective cohort study. Lancet Diabetes Endocrinol. 2020;8(4):292–300. doi:10.1016/S2213-8587(20)30024-3.
   PubMed Web of Science ®Google Scholar
• Brand JS, West J, Tuffnell D, et al. Gestational diabetes and ultrasound-assessed fetal growth in South asian and white european women: findings from a prospective pregnancy cohort. BMC Med. 2018;16(1):203. doi:10.1186/s12916-018-1191-7.
   PubMedGoogle Scholar
• Brittain JJ, Wahl SE, Strauss JF, et al. Prior spontaneous or induced abortion is a risk factor for cervical dysfunction in pregnant women: a systematic review and meta-analysis. Reprod Sci. 2023;30(7):2025–2039. doi:10.1007/s43032-023-01170-7.
   PubMed Web of Science ®Google Scholar
• Chen CY, Chen CY, Liu CC, et al. Omega-3 polyunsaturated fatty acids reduce preterm labor by inhibiting trophoblast cathepsin S and inflammasome activation. Clin Sci (Lond). 2018;132(20):2221–2239. doi:10.1042/CS20180796.
   PubMed Web of Science ®Google Scholar
• Stephenson DJ, MacKnight HP, Hoeferlin LA, et al. Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy. J Lipid Res. 2023;64(6):100377. doi:10.1016/j.jlr.2023.100377.
   PubMed Web of Science ®Google Scholar
• Kovo M, Schreiber L, Bar J. Placental vascular pathology as a mechanism of disease in pregnancy complications. Thromb Res. 2013;131 (Suppl 1):S18–S21. doi:10.1016/S0049-3848(13)70013-6.
   PubMedGoogle Scholar
• Cornish EF, McDonnell T, Williams DJ. Chronic inflammatory placental disorders associated with recurrent adverse pregnancy outcome. Front Immunol. 2022;13:825075. doi:10.3389/fimmu.2022.825075.
   PubMed Web of Science ®Google Scholar
• Kim CJ, Romero R, Chaemsaithong P, et al. Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol. 2015;213(4 Suppl):S53–S69. doi:10.1016/j.ajog.2015.08.041.
   PubMed Web of Science ®Google Scholar
• Bouhadoun A, Manikpurage HD, Deschildre C, et al. DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE(2). Prostaglandins Other Lipid Mediat. 2023;165:106700. doi:10.1016/j.prostaglandins.2022.106700.
   PubMed Web of Science ®Google Scholar
• Stott D, Papastefanou I, Paraschiv D, et al. Longitudinal maternal hemodynamics in pregnancies affected by fetal growth restriction. Ultrasound Obstet Gynecol. 2017;49(6):761–768. doi:10.1002/uog.17340.
   PubMed Web of Science ®Google Scholar
• Song J, Sun R, Zhang Y, et al. Role of the specialized pro-resolving mediator resolvin D1 in hashimoto’s thyroiditis. Exp Clin Endocrinol Diabetes. 2021;129(11):791–797. doi:10.1055/a-1345-0173.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang C, Yang X, et al. Association of maternal thyroid function and thyroidal response to human chorionic gonadotropin with early fetal growth. Thyroid. 2019;29(4):586–594. doi:10.1089/thy.2018.0556.
   PubMed Web of Science ®Google Scholar
• Downes KL, Grantz KL, Shenassa ED. Maternal, labor, delivery, and perinatal outcomes associated with placental abruption: a systematic review. Am J Perinatol. 2017;34(10):935–957. doi:10.1055/s-0037-1599149.
   PubMed Web of Science ®Google Scholar
• Adane AA, Shepherd CCJ, Lim FJ, et al. The impact of pre-pregnancy body mass index and gestational weight gain on placental abruption risk: a systematic review and meta-analysis. Arch Gynecol Obstet. 2019;300(5):1201–1210. doi:10.1007/s00404-019-05320-8.
   PubMed Web of Science ®Google Scholar
• Marasciulo F, Orabona R, Fratelli N, et al. Preeclampsia and late fetal growth restriction. Minerva Obstet Gynecol. 2021;73:435–441.
   PubMedGoogle Scholar
• Dall’Asta A, Melito C, Morganelli G, et al. Determinants of placental insufficiency in fetal growth restriction. Ultrasound Obstet Gynecol. 2023;61(2):152–157. doi:10.1002/uog.26111.
   PubMed Web of Science ®Google Scholar